Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Exchange Rate Effect: 2014-2019

Historic Exchange Rate Effect for Coherus Oncology (CHRS) over the last 6 years, with Dec 2019 value amounting to -$276,000.

  • Coherus Oncology's Exchange Rate Effect fell 176.81% to -$106,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$276,000, marking a year-over-year decrease of 158.97%. This contributed to the annual value of -$276,000 for FY2019, which is 158.97% down from last year.
  • Latest data reveals that Coherus Oncology reported Exchange Rate Effect of -$276,000 as of FY2019, which was down 158.97% from $468,000 recorded in FY2018.
  • Coherus Oncology's Exchange Rate Effect's 5-year high stood at $468,000 during FY2018, with a 5-year trough of -$398,000 in FY2016.
  • For the 3-year period, Coherus Oncology's Exchange Rate Effect averaged around $24,000, with its median value being -$120,000 (2017).
  • Per our database at Business Quant, Coherus Oncology's Exchange Rate Effect crashed by 573.81% in 2016 and then skyrocketed by 490.00% in 2018.
  • Yearly analysis of 5 years shows Coherus Oncology's Exchange Rate Effect stood at $84,000 in 2015, then crashed by 573.81% to -$398,000 in 2016, then surged by 69.85% to -$120,000 in 2017, then soared by 490.00% to $468,000 in 2018, then tumbled by 158.97% to -$276,000 in 2019.